Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03122548 |
Title | Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Aduro Biotech, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Medical Center | Los Angeles | California | 90095 | United States | Details | |
University of Colorado | Aurora | Colorado | 80045 | United States | Details | |
University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
Johns Hopkins University | Baltimore | Maryland | 21287 | United States | Details | |
Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details | |
Virginia Mason Medical Center | Seattle | Washington | 98101 | United States | Details |